• Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems

  • 2022/11/01
  • 再生時間: 4 分
  • ポッドキャスト

Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems

  • サマリー

  • Highly qualified providers offer Exosome Therapy treatments through injection, intravenous, nebulizer, or intranasal. Often, exosomes and mesenchymal stem cells are infused together for optimal results. These exosomes used by R3 Stem Cell Therapy are derived specifically from umbilical cord stem cells. These cells are produced in cGMP-compliant labs (Current Good Manufacturing Practice). The quality assurance standards are equitable to the necessary regulations provided by the US FDA (Food & Drug Administration). According to David Greene, the Founder, and CEO of R3 Stem Cell Therapy,
    続きを読む 一部表示

あらすじ・解説

Highly qualified providers offer Exosome Therapy treatments through injection, intravenous, nebulizer, or intranasal. Often, exosomes and mesenchymal stem cells are infused together for optimal results. These exosomes used by R3 Stem Cell Therapy are derived specifically from umbilical cord stem cells. These cells are produced in cGMP-compliant labs (Current Good Manufacturing Practice). The quality assurance standards are equitable to the necessary regulations provided by the US FDA (Food & Drug Administration). According to David Greene, the Founder, and CEO of R3 Stem Cell Therapy,

Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systemsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。